The WWJ Technology Report’s 2013 Fall Tech Tour starts and ends in Kalamazoo. Today, the beginning: a look at the latest in Michigan’s pharmaceutical and medical device industries, at the annual Conference and Expo of MichBio, the state’s bioscience industries association, at downtown Kalamazoo’s beautiful Radisson hotel.
Grand Valley State University signed a reverse transfer agreement Oct. 13 with Kalamazoo Valley Community College in Kalamazoo.
MichBio, the association for Michigan’s biosciences industry, will welcome more than 300 bioscience professionals and service providers to its ninth annual Expo & Conference, to be held Tuesday and Wednesday, Oct. 15 and 16, at the Radisson Plaza Hotel in Kalamazoo.
Minneapolis-based Imris Inc. and Kalamazoo’s Stryker Corp. announced a non-exclusive collaboration between Stryker’s automatic image registration for spinal and cranial navigated procedures and Imris’ Visius CT and MRI surgical suites.
On Oct. 29, the Southwest Michigan Procurement Technical Assistance Center will hold a special training session to educate local businesses on how to package their goods for shipment to federal military bases around the world and how to use the Wide Area Workflow website as a federal government prime contract award winner.
The West Michigan industrial economy has returned to slow growth, according to the results of a monthly survey compiled by Brian G. Long, director of Supply Management Research in the Seidman College of Business at Grand Valley State University.
NanoVir LLC of Kalamazoo, in partnership with the University of Missouri-St. Louis, has announced the results of a study that characterized the mechanism by which their novel antiviral compounds to prompt cells to selectively destroy human papillomavirus DNA.
As it nears the end of its 10th year, the Southwest Michigan Innovation Center will sponsor two events in October that highlight a decade of achievement, including an inventive online tour showing to the global bioscience industry what makes SMIC and the region a successful life sciences hub.
Metabolic Solutions Development Co. LLC has presented new data showing that an investigational drug being studied to treat diabetes, MSDC-0160, had a protective effect on nerve cells in the brain that control movement, balance and walking. These results in laboratory and animal models of Parkinson’s disease suggest MSDC-0160 may have the potential to modify the course of Parkinson’s disease.
The latest awards and certifications earned by Michigan’s technology-focused companies, institutions and groups